Private Cord Blood Banking: Experiences and Views of Pediatric Hematopoietic Cell Transplantation Physicians

Author:

Thornley Ian1,Eapen Mary2,Sung Lillian3,Lee Stephanie J.4,Davies Stella M.5,Joffe Steven6

Affiliation:

1. Department of Pediatrics, North Shore Medical Center, Salem, Massachusetts

2. Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin

3. Division of Pediatric Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada

4. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

5. Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

6. Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Children's Hospital Boston, Boston, Massachusetts

Abstract

OBJECTIVE. Private cord blood banks are for-profit companies that facilitate storage of umbilical cord blood for personal or family use. Pediatric hematopoietic cell transplantation physicians are currently best situated to use cord blood therapeutically. We sought to describe the experiences and views of these physicians regarding private cord blood banking. PARTICIPANTS AND METHODS. We e-mailed a cross-sectional survey to pediatric hematopoietic cell transplantation physicians in the United States and Canada; 93 of 152 potentially eligible physicians (93 of 130 confirmed survey recipients) from 57 centers responded. Questions addressed the number of transplants performed by using privately banked cord blood, willingness to use banked autologous cord blood in specific clinical settings, and recommendations to parents regarding private cord blood banking. RESULTS. Respondents reported having performed 9 autologous and 41 allogeneic transplants using privately banked cord blood. In 36 of 40 allogeneic cases for which data were available, the cord blood had been collected because of a known indication in the recipient. Few respondents would choose autologous cord blood over alternative stem cell sources for treatment of acute lymphoblastic leukemia in second remission. In contrast, 55% would choose autologous cord blood to treat high-risk neuroblastoma, or to treat severe aplastic anemia in the absence of an available sibling donor. No respondent would recommend private cord blood banking for a newborn with 1 healthy sibling when both parents were of northern European descent; 11% would recommend banking when parents were of different minority ethnicities. CONCLUSIONS. Few transplants have been performed by using cord blood stored in the absence of a known indication in the recipient. Willingness to use banked autologous cord blood varies depending on disease and availability of alternative stem cell sources. Few pediatric hematopoietic cell transplantation physicians endorse private cord blood banking in the absence of an identified recipient, even for mixed-ethnicity children for whom finding a suitably matched unrelated donor may be difficult.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology, and Child Health

Reference54 articles.

1. Cord Blood Registry. Cord blood registry: our pricing. Available at: www.cordblood.com/cord_blood_banking_with_cbr/pricing_domestic.asp. Accessed June 5, 2008

2. Viacord. Viacord pricing and storage plans. Available at: www.viacord.com/pricing-storage-plans.htm. Accessed June 5, 2008

3. Moise KJ. What to tell patients about banking cord blood stem cells. Contemp Ob Gyn. Available at: www.modernmedicine.com/modernmedicine/article/articleDetail.jsp?id=320177&pageID=I&SK=&date=. Accessed January 9, 2009

4. Ferreira E, Pasternak J, Bacal N, de Campos Guerra JC, Mitie Watanabe F. Autologous cord blood transplantation. Bone Marrow Transplant. 1999;24(9):1041

5. Hayani A, Lampeter E, Viswanatha D, Morgan D, Salvi SN. First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics. 2007;119(1). Available at: www.pediatrics.org/cgi/content/full/119/1/e296

Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3